VYNE Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.

About VYNE

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. 

CEO
David Domzalski
CEODavid Domzalski
Employees
13
Employees13
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2011
Founded2011
Employees
13
Employees13

VYNE Key Statistics

Market cap
19.19M
Market cap19.19M
Price-Earnings ratio
-0.36
Price-Earnings ratio-0.36
Dividend yield
—
Dividend yield—
Average volume
5.33M
Average volume5.33M
High today
$0.365
High today$0.365
Low today
$0.3436
Low today$0.3436
Open price
$0.3436
Open price$0.3436
Volume
2.96M
Volume2.96M
52 Week high
$4.30
52 Week high$4.30
52 Week low
$0.3403
52 Week low$0.3403

People also own

Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
NIO
Bionano Genomics
Castor Maritime
Plug Power
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.